002082SZSE

Wanbangde Pharmaceutical Holdings Group Co., Ltd. 2025 Annual Shareholders' Meeting Resolution Announcement

Wanbangde Pharmaceutical Holding Group Co., Ltd.··5 pages

✨ AI Summary

This announcement details the resolutions passed at Wanbangde Pharmaceutical Holdings Group's 2025 Annual Shareholders' Meeting. Key decisions included approving the 2025 Board of Directors' work report, the 2025 profit distribution plan, and the 2026 credit line application. All proposals were passed with high approval rates, indicating strong shareholder support for the company's strategic direction.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002082 Securities Abbreviation: ST Wanbang Announcement No.: 2026-050

Wanbangde Pharmaceutical Holdings Group Co., Ltd. 2025 Annual Shareholders' Meeting Resolution Announcement

The company and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

Special Notes:

  1. No proposals were rejected at this shareholders' meeting.
  2. This shareholders' meeting does not involve any changes to resolutions previously passed by shareholders' meetings.

I. Meeting Convening Situation

  1. Meeting Convening Time
  1. On-site meeting time: 2:00 PM on June 22, 2026.
  2. Online voting time: Voting time through the Shenzhen Stock Exchange trading system was from 9:15-9:25 AM, 9:30-11:30 AM, and 1:00 PM-3:00 PM on June 22, 2026; voting time through the Shenzhen Stock Exchange internet system was any time from 9:15 AM to 3:00 PM on June 22, 2026.

  1. Meeting Venue: Conference room of the company's administrative building, No. 28 Baizhang North Road, Chengdong Street, Wenling City, Taizhou City, Zhejiang Province.

  2. Meeting Convener: The Board of Directors of Wanbangde Pharmaceutical Holdings Group Co., Ltd. (hereinafter referred to as the "Company").

  3. Meeting Chairman: Chairman Mr. Zhao Shouming.

  4. Meeting Method: This meeting was convened using a combination of on-site voting and online voting.

The convening, holding, and voting procedures of the meeting comply with the provisions of the "Company Law" and other relevant laws, regulations, departmental rules, and the "Articles of Association" and other relevant regulations.

II. Meeting Attendance Situation

  1. A total of 203 shareholders or their proxies attended this shareholders' meeting, representing 314,518,631 shares with voting rights, accounting for 51.4181% of the total shares with voting rights.
  1. On-site meeting attendance: A total of 9 shareholders or their proxies attended the on-site voting, representing 249,611,178 shares with voting rights, accounting for 40.8069% of the total shares with voting rights.
  2. Online voting situation: A total of 194 shareholders participated in this shareholders' meeting through online voting, representing 64,907,453 shares with voting rights, accounting for 10.6112% of the total shares with voting rights.
  3. A total of 197 small and medium investors (excluding company directors, senior management, and shareholders holding more than 5% of the company's shares and their concerted parties) attended, representing 5,771,553 shares with voting rights, accounting for 0.9435% of the total shares with voting rights.
  1. Company directors and senior management attended this shareholders' meeting through a combination of on-site and telecommunication methods. Lawyers from Grandall Law Firm (Hangzhou) attended the shareholders' meeting for witnessing and issued a legal opinion.

III. Meeting Deliberation Matters

Voting was conducted through a combination of on-site and online voting for the proposals submitted for deliberation at this meeting, and the following resolutions were formed:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing